Cytek Biosciences, Inc. (CTKB): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

127.75M
Year ended 2025-12-31
-2.7%
3-year compound annual growth
+31.4%
5-year compound annual growth
138.56M2020-12-31: 32.60M2021-12-31: 81.54M2022-12-31: 138.56M2023-12-31: 135.28M2024-12-31: 130.61M2025-12-31: 127.75M127.75M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31127.75M-2.2%2026-02-26, From 2025-01-01
2024-12-31130.61M-3.5%2026-02-26, From 2024-01-01
2023-12-31135.28M-2.4%2026-02-26, From 2023-01-01
2022-12-31138.56M+69.9%2025-02-28, From 2022-01-01
2021-12-3181.54M+150.1%2024-03-13, From 2021-01-01
2020-12-3132.60Mn/a2023-03-01, From 2020-01-01